Status:
COMPLETED
Using Voice Biomarkers to Predict the Likelihood of Major Depressive Disorder
Lead Sponsor:
Kintsugi Mindful Wellness, Inc.
Collaborating Sponsors:
San Francisco Psychiatry Group
Frontier Psychiatry
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-100 years
Brief Summary
Major Depressive Disorder (MDD) is the leading cause of disability worldwide. Depression and anxiety disorders are among the most prevalent of all mental disorders, with an estimated annual prevalence...
Eligibility Criteria
Inclusion
- Adult males and or females over the age of 18 at the time of informed consent
- Access to a laptop, smartphone or tablet with a functioning microphone
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Fluency in English
- For depressed participant group: Current diagnosis of depression
- For non-depressed participant group: No current or prior diagnosis of depression
Exclusion
- Visual impairment that would make it difficult for the participant to follow the instructions
- Motor impairment that would make it difficult for the participant to follow the instructions
- Any known history of neurodegenerative or Central Nervous System disorders (e.g. MS, Dementia, TBI, Stroke, etc.)
- Any known history of major psychiatric disorder other than depression (e.g. Bipolar Disorder, Schizophrenia, etc.)
- Any known history of substance abuse
Key Trial Info
Start Date :
April 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 4 2021
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT04874077
Start Date
April 21 2021
End Date
September 4 2021
Last Update
July 6 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco Psychiatrists, Inc.
San Francisco, California, United States, 94123
2
Frontier Psychiatry
Billings, Montana, United States, 59101